Evoke Pharma, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
The company stated in the following report that they conduct preclinical tests of their drugs on animals to assess it’s safety profile.
“RM-131 is a small-peptide analog of ghrelin, a hormone produced in the stomach that stimulates gastrointestinal activity. The compound is being developed for GI motility disorders and has shown efficacy in surgical and opiate-induced ileus in animal models due to a direct prokinetic effect. RM-131 reverses body weight loss in cachexia models. ” (Page 11) Read the full document.
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops EVK-001 for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded by Matthew J. D’Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in Solana Beach, CA. [Source: MarketWatch]
Company Website: http://www.evokepharma.com